Albany, NY -- (SBWIRE) -- 12/04/2015 -- The high incidence of neurological disorders such as Alzheimer's disease, ischemic stroke, trauma, essential tremors, and particularly Parkinson's disease (PD) is the primary factor boosting the global market for deep brain stimulation devices. In the last couple of years, Parkinson's disease has emerged as one of the most common and progressive neurological disorders, characterized by tremors due to loss of dopamine-producing neurons, postural instability, akinesia, and bradykinesia. According to reports, Parkinson's disease is becoming increasingly prevalent in the U.S. The disease is slightly more common in men, but the prevalence of the disease among the female population also seems to be on the rise in recent years. Whilst a therapeutic approach ensuring complete cure of the disease is yet to be discovered, science has made some major improvements in slowing its impact on patients over time.

Read Full Article: http://www.transparencymarketresearch.com/article/deep-brain-stimulator-market.htm

What is Deep Brain Stimulation and How Does It Help Treat Patients with Neurological Disorders?

Deep brain stimulation, also known as DBS, is a surgical procedure in which a pacemaker-like device is implanted to send signals to the brain areas that are responsible for body movement. In the surgical process, electrodes are placed at a remote brain location. These are then connected to a stimulator or battery device. A neurostimulator is also placed in the setup, which uses the electric pulses sent by electrodes to regulate brain activities. DBS has achieved much significance in the healthcare industry in the last few years, due to its ability to reduce symptoms such as slowness of movement, tremors, walking problems, and stiffness, which are common in people suffering from movement disorders. Deep brain stimulation has therefore emerged as a viable option for patients suffering from any type of movement disorder, such as Parkinson's disease or dystonia. A successful DBS procedure allows patients to better manage the symptoms, effectively bring down their medication, and improve the overall quality of their life.

In a recently published market report, Transparency Market Research has forecast that the global deep brain stimulation (DBS) devices market will exhibit a robust CAGR of 11% from 2013 to 2019. If the forecast holds true, the global DBS market, which stood at US$4.5 bn in 2012, will reach US$9.4 bn in 2019.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435

High Incidence of Neurological Disorders in Developed Regions to Boost Global Deep Brain Stimulation Devices Market

The global deep brain stimulation market can be segmented into Asia Pacific, Europe, North America, and Rest of the World (RoW), on the basis of geography. Countries such as the U.K, India, Japan, China, Canada, France, China, Italy, Spain, Germany, Australia, Brazil, and the U.S. are the leading markets for deep brain stimulation devices. At present, these countries boast of advanced treatment options for patients suffering from neurological disorders and hence, these countries also represent the most lucrative markets for deep brain stimulation devices. Presently, the majority of surgical interventions include DBS devices and they are also considered a more effective and safer option for treating neurological disorders. The global DBS devices market for treating Parkinson's disease stood at close to US$1.8 bn in 2013. Among the four major regional markets, North America held the largest share in the global DBS devices market. North America also held the leading position in terms of revenue, with a 43.0% share in the global DBS devices market for PD in 2013.

Browse Full Global Deep Brain Stimulation Devices Market Report With Complete TOC @ http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/